Press releases

All Releases
View Summary Aastrom Announces Definitive Agreement to Acquire Sanofi's Cell Therapy and Regenerative Medicine Business
Apr 21, 2014
PDF 12.4 KB Add to Briefcase
View Summary Aastrom Reports Data and Safety Monitoring Board Recommendation to Continue ixCELL-DCM Clinical Trial
Apr 9, 2014
PDF 11.2 KB Add to Briefcase
View Summary Aastrom Announces Appointments of Dr. Ross Tubo as Chief Scientific Officer and Dr. David Recker as Chief Medical Officer
Apr 1, 2014
PDF 12.0 KB Add to Briefcase
View Summary Aastrom Biosciences to Present at the 2014 Regen Med Investor Day
Mar 19, 2014
PDF 11.3 KB Add to Briefcase
View Summary Aastrom Biosciences Reports Fourth-Quarter and Year-End 2013 Financial Results
Mar 13, 2014
PDF 19.2 KB Add to Briefcase
View Summary Aastrom Biosciences to Host Fourth Quarter 2013 Investor Call on March 13, 2014
Mar 6, 2014
PDF 12.7 KB Add to Briefcase
View Summary Aastrom Biosciences Enters Into $15 Million Equity Commitment With Lincoln Park Capital
Jan 27, 2014
PDF 12.4 KB Add to Briefcase
View Summary Aastrom Biosciences Granted Composition-of-Matter Patent for Ixmyelocel-T in Australia
Dec 19, 2013
PDF 11.1 KB Add to Briefcase
View Summary Aastrom Biosciences Regains Compliance With NASDAQ Equity Standard Listing Requirement
Nov 15, 2013
PDF 10.7 KB Add to Briefcase
View Summary Aastrom Biosciences Reports Third-Quarter and Nine-Month 2013 Financial Results
Nov 12, 2013
PDF 19.5 KB Add to Briefcase
View Summary Aastrom Biosciences to Present at the 2013 Therapeutic Area Partnerships Conference
Nov 12, 2013
PDF 11.2 KB Add to Briefcase
View Summary Aastrom Biosciences to Host Third Quarter 2013 Investor Call on November 12, 2013
Nov 7, 2013
PDF 12.0 KB Add to Briefcase
View Summary Aastrom Announces Results of Two Studies of Ixmyelocel-T Published in Stem Cell Research & Therapy
Nov 1, 2013
PDF 13.4 KB Add to Briefcase
View Summary Aastrom Biosciences Regains Compliance With NASDAQ Minimum Bid Requirement
Oct 31, 2013
PDF 10.5 KB Add to Briefcase
View Summary Aastrom Biosciences One-for-Twenty Reverse Stock Split Now Effective
Oct 16, 2013
PDF 10.9 KB Add to Briefcase
View Summary Aastrom Biosciences Announces One-for-Twenty Reverse Stock Split
Oct 10, 2013
PDF 11.4 KB Add to Briefcase
View Summary Aastrom Biosciences to Present at the 2013 Stem Cell Meeting on the Mesa Conference
Oct 10, 2013
PDF 11.0 KB Add to Briefcase
View Summary Aastrom Biosciences to Present at the Aegis Capital 2013 Healthcare Conference
Sep 19, 2013
PDF 10.7 KB Add to Briefcase
View Summary Aastrom Clinical Trial Application for Phase 2b ixCELL-DCM Study of ixmyelocel-T Approved in Canada
Sep 16, 2013
PDF 11.2 KB Add to Briefcase
View Summary Heidi Hagen Joins Aastrom Board of Directors
Aug 26, 2013
PDF 11.2 KB Add to Briefcase
Showing 1-20 of 345 Page: 1 2 3 4 5 ... 18  Next 20
Add to Briefcase = add release to Briefcase
Stock Information
NASDAQ: ASTM
Price:
4.36
Change:
0.00
Day High:
4.42
Day Low:
4.22
Volume:
127,800
4:00 PM ET on Apr 23, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools